| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2021 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 500 | $90.00 | $45,001.00 | -0.3% | -17.2% | -70.1% | |
| Jun 8, 2021 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 12,073 | $105.21 | $1,270,172.56 | -19.8% | +17.1% | -62.8% | |
| Jun 8, 2021 | CSTL Castle Biosciences Inc | Spiess Bernhard E. | Chief Business Officer | Sell | 8,989 | $70.00 | $629,230.00 | -39.9% | +5.5% | -70.0% | |
| Jun 8, 2021 | TWST Twist Bioscience Corp | Thorburn James M84 | Chief Financial Officer | Sell | 8,000 | $103.38 | $827,040.00 | -14.6% | +8.9% | -70.0% | |
| Jun 8, 2021 | PSNL Personalis, Inc. | West John Stephen91 | President And CEO | Sell | 110,000 | $22.43 | $2,467,272.50 | -8.9% | -0.5% | -80.7% | |
| Jun 8, 2021 | CDNA Caredx, Inc. | King Sasha77 | Chief Marketing Officer | Sell | 1,000 | $90.02 | $90,024.00 | -2.1% | -17.2% | -70.1% | |
| Jun 8, 2021 | CDNA Caredx, Inc. | Maag Peter83 | Executive Chair | Sell | 978 | $90.05 | $88,073.69 | -0.3% | -17.2% | -70.1% | |
| Jun 8, 2021 | NEO Neogenomics Inc | Crowther Bruce K | Director | Sell | 20,734 | $41.46 | $859,631.64 | -29.5% | +23.4% | -79.6% | |
| Jun 7, 2021 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 9,973 | $90.01 | $897,643.80 | -6.5% | -16.0% | -70.0% | |
| Jun 7, 2021 | NOTV Inotiv, Inc. | Sagartz John E60 | Chief Strategy Officer | Buy | 1,742 | $28.70 | $49,995.40 | +0.3% | +11.0% | -44.2% | |
| Jun 7, 2021 | CDNA Caredx, Inc. | King Sasha77 | Chief Marketing Officer | Sell | 8,071 | $90.01 | $726,461.02 | -14.5% | -16.0% | -70.0% | |
| Jun 7, 2021 | CDNA Caredx, Inc. | Maag Peter83 | Executive Chair | Sell | 26,500 | $86.25 | $2,285,752.20 | -3.4% | -16.0% | -70.0% | |
| Jun 4, 2021 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 9,081 | $34.63 | $314,515.27 | -5.1% | +60.8% | -48.0% | |
| Jun 4, 2021 | CRL Charles River Laboratories International, Inc. | Knell Michael Gunnar67 | Csvp&Chief Accounting Officer | Sell | 1,527 | $335.24 | $511,905.98 | -26.5% | +33.3% | -27.9% | |
| Jun 4, 2021 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Chief Legal Officer | Sell | 3,140 | $97.51 | $306,171.67 | -6.2% | +26.7% | -62.1% | |
| Jun 4, 2021 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 4,709 | $97.51 | $459,159.99 | -5.7% | +26.7% | -62.1% | |
| Jun 4, 2021 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 3,489 | $97.51 | $340,201.57 | -3.6% | +26.7% | -62.1% | |
| Jun 4, 2021 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 4,395 | $97.51 | $428,542.83 | -14.3% | +26.7% | -62.1% | |
| Jun 4, 2021 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 1,250 | $73.18 | $91,474.06 | -0.4% | +27.6% | -29.2% | |
| Jun 3, 2021 | CRL Charles River Laboratories International, Inc. | Knell Michael Gunnar67 | Csvp&Chief Accounting Officer | Sell | 800 | $329.76 | $263,808.88 | -15.9% | +33.8% | -26.7% | |
| Jun 3, 2021 | FLGT Fulgent Genetics, Inc. | Bolger John C65 | Director | Sell | 125 | $74.17 | $9,271.25 | -5.9% | +29.6% | -26.7% | |
| Jun 3, 2021 | VCYT Veracyte, Inc. | Holstein Jens | Director | Buy | 2,000 | $35.19 | $70,389.20 | New | +52.3% | -49.5% | |
| Jun 3, 2021 | PRPH Prophase Labs, Inc. | Karkus Ted William | CEO &Chairman | Buy | 33,943 | $5.07 | $171,921.30 | +1.5% | +6.8% | +115.0% | |
| Jun 3, 2021 | NEO Neogenomics Inc | Cardoza George | President, Pharma Services | Sell | 200,337 | $40.35 | $8,082,901.47 | -34.2% | +25.3% | -79.9% | |
| Jun 2, 2021 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 2,899 | $21.57 | $62,531.43 | -1.5% | -2.0% | -82.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.